Proceedings of the National Academy of Sciences · 2019 · 24 citations · 32 references
Life SciencesGeneticsMolecular BiologyCell SignalingMolecular OncologySignal TransductionBcl-2 Family ProteinsHypoxia AdaptationOncogene MutationsBh3-only Protein FunctionErk SignalingExtracellular Signal-regulated Kinase PathwayGermline MutationsPhenotype-genotype CorrelationPhenotype-genotype LinkingVon Hippel-lindau DiseaseVon Hippel-lindau Syndrome
type 2C mutations. We found that BIM-EL, a proapoptotic BH3-only protein, is hydroxylated by EglN3 and subsequently bound by VHL. VHL mutants fail to bind hydroxylated BIM-EL, regardless of whether they have the ability to bind hydroxylated HIFα or not. VHL binding inhibits BIM-EL phosphorylation by extracellular signal-related kinase (ERK) on serine 69. This causes BIM-EL to escape from proteasomal degradation, allowing it to enhance EglN3-induced apoptosis. BIM-EL was rapidly degraded in cells lacking wild-type VHL or in which EglN3 was inactivated genetically or by lack of oxygen, leading to enhanced cell survival and chemotherapy resistance. Combination therapy using ERK inhibitors, however, resensitizes VHL- and EglN3-deficient cells that are otherwise cisplatin-resistant.
32